Literature DB >> 23796701

Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy.

Keita Matsuura1, Masayuki Maeda, Kenichiro Yata, Yoshito Ichiba, Tomoya Yamaguchi, Kenji Kanamaru, Hidekazu Tomimoto.   

Abstract

Pigmented neurons in the substantia nigra pars compacta (SNc) and locus coeruleus (LC) show decreased numbers differentially in Parkinson's disease (PD) and multiple system atrophy (MSA). Recent reports have described that fast spin-echo T1-weighted magnetic resonance imaging (MRI) by a 3-tesla machine can visualize neuromelanin-related contrast of the noradrenergic and dopaminergic neurons respectively in the LC and the SNc. Using neuromelanin MRI at 3 T, we investigated possible alterations of these catecholaminergic neurons in 32 PD and 9 MSA patients, and compared the results with those of 23 normal volunteers. The contrast ratio of the LC and SNc was decreased in MSA and PD patients, most prominently in the LC in MSA patients. The contrast ratio of the SNc was correlated with the Hoehn-Yahr stage of PD and the severity of neuroradiological abnormalities in MSA. These results indicate a potential diagnostic value of neuromelanin MRI to distinguish MSA patients from normal and PD patients.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796701     DOI: 10.1159/000350291

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  41 in total

1.  Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Donghyun Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Jae Hyoung Kim
Journal:  Eur Radiol       Date:  2020-09-04       Impact factor: 5.315

2.  The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.

Authors:  Xiangming Wang; Yuehui Zhang; Chen Zhu; Guangzong Li; Jie Kang; Fang Chen; Ling Yang
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

3.  A multicontrast approach for comprehensive imaging of substantia nigra.

Authors:  Jason Langley; Daniel E Huddleston; Xiangchuan Chen; Jan Sedlacik; Nishant Zachariah; Xiaoping Hu
Journal:  Neuroimage       Date:  2015-02-28       Impact factor: 6.556

4.  Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.

Authors:  Taku Hatano; Ayami Okuzumi; Koji Kamagata; Kensuke Daida; Daisuke Taniguchi; Masaaki Hori; Hiroyo Yoshino; Shigeki Aoki; Nobutaka Hattori
Journal:  J Neural Transm (Vienna)       Date:  2017-02-03       Impact factor: 3.575

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

6.  Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.

Authors:  Noam I Keren; Saeid Taheri; Elena M Vazey; Paul S Morgan; Ann-Charlotte E Granholm; Gary S Aston-Jones; Mark A Eckert
Journal:  Neuroimage       Date:  2015-03-17       Impact factor: 6.556

Review 7.  Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.

Authors:  Sara Pietracupa; Antonio Martin-Bastida; Paola Piccini
Journal:  Neurol Sci       Date:  2017-09-02       Impact factor: 3.307

8.  Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Authors:  Antonio Martín-Bastida; Nicholas P Lao-Kaim; Andreas Antonios Roussakis; Graham E Searle; Yue Xing; Roger N Gunn; Stefan T Schwarz; Roger A Barker; Dorothee P Auer; Paola Piccini
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

9.  Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.

Authors:  Jason Langley; Daniel E Huddleston; Michael Merritt; Xiangchuan Chen; Rebecca McMurray; Michael Silver; Stewart A Factor; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2016-03-29       Impact factor: 5.038

10.  Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.

Authors:  Paula Trujillo; Paul E Summers; Alex K Smith; Seth A Smith; Luca T Mainardi; Sergio Cerutti; Daniel O Claassen; Antonella Costa
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.